Literature DB >> 2066954

Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia.

D Buskila1, S Sukenik, G Holcberg, J Horowitz.   

Abstract

We describe a woman with psoriatic arthritis who experienced a remarkable improvement of her skin and joint disease while only taking bromocriptine therapy. She was treated with bromocriptine for primary infertility due to hyperprolactinemia. The improvement in joint symptoms appeared to parallel that of the skin. More studies are required to determine the reproducibility of this observation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066954

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  1 in total

1.  Polymorphism of the prolactin extrapituitary promoter in psoriatic arthritis.

Authors:  Jirí Stolfa; Markéta Fojtíková; Pavlína Cejková; Marie Cerná; Liliana Sedová; Ctibor Dostál
Journal:  Rheumatol Int       Date:  2007-06-13       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.